Europe Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Aci

Europe Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028. It is estimated to record a CAGR of 9.3% from 2021 to 2028.

Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches Fuels Europe Sepsis Diagnostics Market Growth

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfil this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. In September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model. The model shows that the use of the company's HostDxTM Sepsis test is cost-effective as compared to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in emergency departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. Thus, the rising demand for rapid diagnostics tests led to product launches, which is expected to drive the Europe sepsis diagnostics market during the forecast period.

Europe Sepsis Diagnostics Market Overview

The Europe sepsis diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Germany holds a significant market share in the Europe sepsis diagnostics market and is estimated to register a robust growth rate over the forecast period. Germany and the UK are expected to contribute majorly to the growth of the market in Europe. The Europe sepsis diagnostics market is expected to witness a significant growth during the forecast period due to factors such as the need for early diagnosis of sepsis, the high mortality rate of the medical condition, and its increasing prevalence.

Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented the basis of product, technology, method, test type, pathogen, end user, and country.

Based on product, the Europe sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Europe sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Europe sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Europe sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Europe sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Europe sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2021.

Abbott; Axis-Shield Diagnostics Ltd; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. Are among the leading companies operating in the Europe sepsis diagnostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sepsis diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sepsis diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution